MAPT and Alzheimer disease: Surprisingly, we observed decreased levels of Aβ42 (Fig. 5A, p < 0.0001), total tau (Fig. 5C, p < 0.0001) and pTau 181(Fig. 5E, p < 0.0001) in protein lysates obtained from the brain channel of AD brain-chips.